World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
36556
World Ranking
10781
National Ranking
5546

Overview

David S. Ettinger is affiliated with Johns Hopkins University in the United States and has contributed extensively to medical research, particularly in the field of oncology. Their work primarily focuses on lung cancer, immunotherapy, and cancer diagnostics.

Their research spans several main fields of study, including Medicine, with subfields such as Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Pathology and Forensic Medicine, and Molecular Biology. Key topics covered in their publications include:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Immunotherapy and Immune Responses

David S. Ettinger has authored numerous papers, with several recent notable publications in the Journal of the National Comprehensive Cancer Network and JAMA Oncology. These include:

  • Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021, 2021, Journal of the National Comprehensive Cancer Network
  • Non-Small Cell Lung Cancer, Version 4.2024, 2024, Journal of the National Comprehensive Cancer Network (authored by Gregory J. Riely, cited alongside Ettinger's work)
  • Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer, 2020, JAMA Oncology
  • NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023, 2023, Journal of the National Comprehensive Cancer Network

Frequent collaborators in their research include Patrick M. Forde, Julie R. Brahmer, Kristen A. Marrone, Christine L. Hann, and Josephine Feliciano. These coauthors have worked alongside Ettinger on multiple occasions, contributing to a significant body of publications in oncology and related fields.

Their research has been published predominantly in the following venues:

  • ONCOLOGY
  • Journal of the National Comprehensive Cancer Network
  • Cancer Research
  • JAMA Oncology
  • Clinical Lung Cancer

David S. Ettinger's contributions to medicine focus particularly on advancing the understanding and clinical guidelines related to non-small cell lung cancer. Their work includes clinical practice guidelines and insights into immunotherapy side effects, shaping current approaches in diagnosis and treatment within the domain of pulmonary and cancer medicine.

Best Publications

  • Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.

    William P. McGuire;Eric K. Rowinsky;Neil B. Rosenshein;Francis C. Grumbine

  • Non–Small Cell Lung Cancer

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Andrew Chang

  • Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology

    David S. Ettinger;Douglas E. Wood;Dara L. Aisner;Wallace Akerley

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • American Cancer Society lung cancer screening guidelines

    Richard Wender;Elizabeth T.H. Fontham;Ermilo Barrera;Ermilo Barrera;Graham A. Colditz

  • Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

    David S. Ettinger;Douglas E. Wood;Charu Aggarwal;Dara L. Aisner

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    David S. Ettinger;David S. Ettinger;Douglas E. Wood;Douglas E. Wood;Dara L. Aisner;Wallace Akerley;Wallace Akerley

  • Small cell lung cancer.

    Gregory P. Kalemkerian;Wallace Akerley;Robert J. Downey;David S. Ettinger

  • Sequences of Taxol and Cisplatin: A Phase I and Pharmacologic Study

    E K Rowinsky;M R Gilbert;W P McGuire;D A Noe

  • Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

    Douglas E. Wood;Ella A. Kazerooni;Scott L. Baum;Georgie A Eapen

  • Non-small cell lung cancer: Clinical practice guidelines in oncology

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Matthew G. Blum

  • Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines

    David S. Ettinger;Wallace Akerley;Hossein Borghaei;Andrew C. Chang

  • Non–Small Cell Lung Cancer, Version 6.2015

    David S. Ettinger;Douglas E. Wood;Wallace Akerley;Lyudmila A. Bazhenova

  • NCCN Guidelines ® Insights: Non-Small Cell Lung Cancer, Version 4.2016 Featured Updates to the NCCN Guidelines

    David S. Ettinger;Douglas E. Wood;Wallace Akerley;Lyudmila A. Bazhenova

  • Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

    E K Rowinsky;L B Grochow;C B Hendricks;D S Ettinger

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

    David S. Ettinger;Dara L. Aisner;Douglas E. Wood;Wallace Akerley

  • Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.

    D M Finkelstein;D S Ettinger;J C Ruckdeschel

  • A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

    John C. Ruckdeschel;Dianne M. Finkelstein;David S. Ettinger;Richard H. Creech

  • Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

    S. A. Grossman;D. M. Finkelstein;J. C. Ruckdeschel;D. L. Trump

  • Malignant pleural mesothelioma.

    David S. Ettinger;Wallace Akerley;Hossein Borghaei;Andrew Chang

Frequent Co-Authors

Ross C. Donehower
Ross C. Donehower Johns Hopkins University
Julie R. Brahmer
Julie R. Brahmer Johns Hopkins University
Eric K. Rowinsky
Eric K. Rowinsky Eli Lilly (United States)
Gregory A. Otterson
Gregory A. Otterson The Ohio State University
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Thomas A. D'Amico
Thomas A. D'Amico Duke University
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Lucian R. Chirieac
Lucian R. Chirieac Brigham and Women's Hospital
Corey J. Langer
Corey J. Langer University of Pennsylvania
Gregory J. Riely
Gregory J. Riely Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Choosing to study Medicine in the USA often opens the door to a wide range of related degrees and healthcare careers. For those seeking a fast and practical start, nursing remains one of the most accessible options. Some schools even offer an lpn program no entrance exam, making this career path especially appealing for students looking to enter the workforce quickly without standardized test hurdles.

If you’re interested in medical leadership or hospital management, consider pursuing a healthcare administration associate degree online. This pathway can lead to vital roles managing healthcare teams and systems, and many degrees are offered in flexible or accelerated formats.

Nurses aiming for advanced practice can bridge to higher qualifications with programs like asn to fnp programs, allowing registered nurses to become family nurse practitioners and provide primary care.

Other growing fields include nutrition and wellness. Those looking to build a career in dietary health can explore the best online nutrition degree programs, which lay a foundation for jobs in clinical nutrition, public health, or wellness coaching.

Best Scientists Citing David S. Ettinger

Trending Scientists

Recently Published Articles